Australia - English - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - ascorbic acid,calcium citrate tetrahydrate,calcium hydrogen phosphate dihydrate,calcium phosphate,colecalciferol,dibasic potassium phosphate,magnesium amino acid chelate,magnesium orotate dihydrate,magnesium phosphate tribasic,manganese amino acid chelate,pyridoxine hydrochloride,zinc gluconate -

Australia - English - Department of Health (Therapeutic Goods Administration)

metagenics (aust) pty ltd - ascorbic acid,betacarotene,borax,biotin,calcium amino acid chelate,calcium citrate tetrahydrate,calcium hydrogen phosphate dihydrate,calcium pantothenate,chromic chloride hexahydrate,colecalciferol,cyanocobalamin,d-alpha-tocopheryl acid succinate,dibasic potassium phosphate,folic acid,heavy magnesium oxide,magnesium amino acid chelate,manganese amino acid chelate,mixed (low-alpha type) tocopherols concentrate,molybdenum trioxide,nicotinamide,phytomenadione,potassium iodide,pyridoxal -

United States - English - NLM (National Library of Medicine)

flon laboratories llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febril states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid

United States - English - NLM (National Library of Medicine)

raw materials international overseas llc - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r) - ascorbic acid 500 mg in 1 ml - ascorbic acid is recommended for the prevention and treatment of scurvy. its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain. symptoms of mild deficiency may include faulty bone and tooth development, gingivitis, bleeding gums, and loosened teeth. febrile states, chronic illness, and infection (pneumonia, whooping cough, tuberculosis, diphtheria, sinusitis, rheumatic fever, etc.) increases the need for ascorbic acid. hemovascular disorders, burns, delayed fracture and wound healing are indications for an increase in the daily intake. there are no contraindications to the administration of ascorbic acid.

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi,kenya - ascorbic acid - chewable tablet - ascorbic acid 100mg per tablet. - plain ascorbic acid (vitamin c)

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi, kenya - ascorbic acid - chewable tablet - ascorbic acid 250mg per tablet - plain ascorbic acid (vitamin c)

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi, kenya - ascorbic acid - chewable tablet - ascorbic acid 500mg per tablet - plain ascorbic acid (vitamin c)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

healthcare pharma ltd - ascorbic acid - oral tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - ascorbic acid - oral tablet - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

crescent pharma ltd - ascorbic acid - oral tablet - 50mg